3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
5
Withdrawn
1
Not yet recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
63
Cisplatin
41
Pemetrexed
39
Drug Therapy
37
anlotinib
23
osimertinib
22
Etoposide
19
tislelizumab
18
Paclitaxel
18
Radiotherapy
17
Surgical Procedures, Operative
16
pembrolizumab
15
toripalimab
14
130-nm albumin-bound paclitaxel
14
aflutinib
13
Docetaxel
13
Bevacizumab
12
sintilimab
10
Specimen Handling
10
Magnetic Resonance Spectroscopy
10
durvalumab
9
Injections
9
cemiplimab
8
Radiosurgery
8
Platinum
8
PM 01183
8
Immunotherapy
8
atezolizumab
7
Platinum Compounds
7
Blood Specimen Collection
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
JDQ443
×
Thoracic
×
Clear all
NCT07468071
2026-04-02
KontRASt-R
Novartis
Phase 1/2
Not yet recruiting
40 enrolled